180 related articles for article (PubMed ID: 15468939)
1. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
[TBL] [Abstract][Full Text] [Related]
2. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
Lew YS; Kolozsvary A; Brown SL; Kim JH
Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
[TBL] [Abstract][Full Text] [Related]
4. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
[TBL] [Abstract][Full Text] [Related]
5. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
Griffin RJ; Williams BW; Park HJ; Song CW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358
[TBL] [Abstract][Full Text] [Related]
6. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
7. Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts.
Xie LX; Lin XH; Li DR; Chen JY; Hong CQ; Du CW
Exp Oncol; 2007 Mar; 29(1):45-8. PubMed ID: 17431388
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.
Lew YS; Brown SL; Griffin RJ; Song CW; Kim JH
Cancer Res; 1999 Dec; 59(24):6033-7. PubMed ID: 10626785
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
[TBL] [Abstract][Full Text] [Related]
11. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
[TBL] [Abstract][Full Text] [Related]
17. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
18. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp.
Han B; Zhou G; Zhang Q; Zhang J; Wang X; Tang W; Kakudo K
J Exp Ther Oncol; 2004 Dec; 4(4):335-42. PubMed ID: 15844663
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
20. A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer.
Huilgol NG
Int J Hyperthermia; 2006 Aug; 22(5):391-7. PubMed ID: 16891241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
